Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Recognizing hospitalized heart failure as an entity and developing new therapies to improve outcomes: academics', clinicians', industry's, regulators', and payers' perspectives.

Gheorghiade M, Shah AN, Vaduganathan M, Butler J, Bonow RO, Rosano GM, Taylor S, Kupfer S, Misselwitz F, Sharma A, Fonarow GC.

Heart Fail Clin. 2013 Jul;9(3):285-90, v-vi. doi: 10.1016/j.hfc.2013.05.002. Review.

PMID:
23809415
2.

Classification of patients hospitalized for heart failure.

Vaduganathan M, Marti CN, Georgiopoulou VV, Kalogeropoulos AP, Butler J.

Heart Fail Clin. 2013 Jul;9(3):277-83, v. doi: 10.1016/j.hfc.2013.04.002. Epub 2013 May 30. Review.

PMID:
23809414
3.

Rehospitalization for heart failure: problems and perspectives.

Gheorghiade M, Vaduganathan M, Fonarow GC, Bonow RO.

J Am Coll Cardiol. 2013 Jan 29;61(4):391-403. doi: 10.1016/j.jacc.2012.09.038. Epub 2012 Dec 5.

4.

The potential role of nonpharmacologic electrophysiology-based interventions in improving outcomes in patients hospitalized for heart failure.

Wang NC, Piccini JP, Fonarow GC, Knight BP, Harinstein ME, Butler J, Lahiri MK, Metra M, Vaduganathan M, Gheorghiade M.

Heart Fail Clin. 2013 Jul;9(3):331-43, vi-vii. doi: 10.1016/j.hfc.2013.04.007. Review.

PMID:
23809419
5.
6.

Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries.

Greene SJ, Shah AN, Butler J, Ambrosy AP, Anker SD, Chioncel O, Collins SP, Dinh W, Dunnmon PM, Fonarow GC, Lam CS, Mentz RJ, Pieske B, Roessig L, Rosano GM, Sato N, Vaduganathan M, Gheorghiade M.

Am Heart J. 2014 Aug;168(2):142-9. doi: 10.1016/j.ahj.2014.05.009. Epub 2014 May 24.

7.

Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry.

O'Connor CM, Stough WG, Gallup DS, Hasselblad V, Gheorghiade M.

J Card Fail. 2005 Apr;11(3):200-5.

PMID:
15812748
8.

New technologies and potential cost savings related to morbidity and mortality reduction in Class III/IV heart failure patients in Canada.

Bentkover JD, Stewart EJ, Ignaszewski A, Lepage S, Liu P, Cooper J.

Int J Cardiol. 2003 Mar;88(1):33-41.

PMID:
12659982
9.

Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.

Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O'Connor CM, Yancy CW, Young J.

Am Heart J. 2004 Jul;148(1):43-51.

PMID:
15215791
10.

Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry).

Sato N, Kajimoto K, Keida T, Mizuno M, Minami Y, Yumino D, Asai K, Murai K, Muanakata R, Aokage T, Sakata Y, Mizuno K, Takano T; TEND Investigators..

Circ J. 2013;77(4):944-51. Epub 2013 Mar 15.

11.

Economic effects of beta-blocker therapy in patients with heart failure.

Cowper PA, DeLong ER, Whellan DJ, Allen LaPointe NM, Califf RM.

Am J Med. 2004 Jan 15;116(2):104-11.

PMID:
14715324
12.

Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial.

Ambrosy AP, Pang PS, Khan S, Konstam MA, Fonarow GC, Traver B, Maggioni AP, Cook T, Swedberg K, Burnett JC Jr, Grinfeld L, Udelson JE, Zannad F, Gheorghiade M; EVEREST Trial Investigators..

Eur Heart J. 2013 Mar;34(11):835-43. doi: 10.1093/eurheartj/ehs444. Epub 2013 Jan 4.

PMID:
23293303
13.

Cost-consequences of ultrafiltration for acute heart failure: a decision model analysis.

Bradley SM, Levy WC, Veenstra DL.

Circ Cardiovasc Qual Outcomes. 2009 Nov;2(6):566-73. doi: 10.1161/CIRCOUTCOMES.109.853556. Epub 2009 Nov 3.

14.
15.

Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claims.

Kociol RD, Hammill BG, Hernandez AF, Klaskala W, Mills RM, Curtis LH, Fonarow GC.

Clin Cardiol. 2011 Nov;34(11):682-8. doi: 10.1002/clc.20986. Epub 2011 Nov 6.

16.

Hospital cost effect of a heart failure disease management program: the Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) trial.

Gregory D, Kimmelstiel C, Perry K, Parikh A, Konstam V, Konstam MA.

Am Heart J. 2006 May;151(5):1013-8.

PMID:
16644325
17.

Strategies to reduce hospitalization in the management of heart failure.

Berkowitz R, Blank LJ, Powell SK.

Lippincotts Case Manag. 2005 Nov-Dec;10(6 Suppl):S1-15; quiz S16-7.

PMID:
16314728
18.

Economic burden of heart failure: a summary of recent literature.

Lee WC, Chavez YE, Baker T, Luce BR.

Heart Lung. 2004 Nov-Dec;33(6):362-71. Review.

PMID:
15597290
19.
20.

Heart failure disease management: implementation and outcomes.

Whellan DJ.

Cardiol Rev. 2005 Sep-Oct;13(5):231-9. Review.

PMID:
16106184

Supplemental Content

Support Center